TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
KYMR

Kymera Therapeutics Inc

Healthcare · Biotechnology

115.80$ +0.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KYMR
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
94.5% 79.6% 62.1% 74.5% 69.5% 70.4% 52.2% 50.0%
93.3% 65.1% 6.4% 7.9% 11.3% 19.1% 12.3% 20.5%
93.3% 78.8% 60.8% 73.0% 67.5% 65.1% 50.0% 48.7%
0.3% 0.2% 0.3% 0.0% 0.4% 3.3% 0.1% –
– – -33.5% -1.5% -2.0% 0.0% – –
5.1% 18.9% 4.2% 2.0% 2.2% – – –
177.9% 163.8% 41.7% 24.1% 18.7% 31.4% 14.6% 9.4%
10.6% 29.6% 22.7% 15.3% 11.8% 14.9% 6.9% 4.8%
0.7% 2.9% 0.7% 0.6% 0.7% 1.1% 1.3% 0.8%
4.6% 2.8% 0.9% 0.7% 0.7% 1.2% 0.6% 0.2%
-77.9% -63.8% 58.3% 75.9% 81.3% 68.6% 85.4% 90.6%
-79.6% -65.5% -26.4% -37.8% -63.6% -92.2% -77.2% -61.2%
100.7% 38.2% 9.1% 7.9% 8.9% 10.1% 7.7% 4.8%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?